• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.17%

    Nektar Therapeutics (NKTR)

    -NasdaqGS
    13.45 Up 0.25(1.89%) Feb 24, 4:00PM EST
    |After Hours : 13.36 Down 0.09 (0.65%) Feb 24, 4:38PM EST
    Prev Close:13.20
    Open:13.09
    Bid:10.28 x 100
    Ask:16.87 x 200
    1y Target Est:19.75
    Beta:2.32773
    Next Earnings Date: 1-Mar-17NKTR Earnings announcement
    Day's Range:13.04 - 13.46
    52wk Range:10.67 - 19.98
    Volume:839,408
    Avg Vol (3m):1,164,330
    Market Cap:2.06B
    P/E (ttm):N/A
    EPS (ttm):-1.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NKTR

    Comparison

    Symbol% ChgMkt Cap
    NKTRUp 1.89%2.06B
    GSKUp 0.17%98.64B
    ENZNDown 2.08%14.37M
    BMYUp 1.20%94.32B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.07
    Quarterly EPS Est (Dec-16) :-0.26
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):1.69

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Nektar Therapeutics develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback